Tesamorelin
Tesamorelin image 1Tesamorelin image 2
Clinically Proven to Reduce Visceral Fat & Boost VitalityStandardReport Available

Tesamorelin

Research overview

<p> Tesamorelin is a synthetic growth hormone releasing hormone analogue commonly researched for growth hormone signalling pathways, IGF-1 modulation models, metabolic regulation investigations, and peptide-based endocrine research applications. </p> <p> Research involving Tesamorelin has explored pulsatile growth hormone release dynamics, body composition pathway investigations, visceral fat signalling models, recovery-focused peptide studies, and metabolic optimisation research under controlled laboratory conditions. </p> <p> Tesamorelin peptide research is frequently associated with growth hormone secretagogue studies, recovery optimisation models, metabolic pathway investigations, performance-focused peptide research, and advanced endocrine signalling applications. </p> <p> This Vital Edge Science batch features Janoshik-verified Tesamorelin with a reported purity of 99.600% and independently verified analytical testing. </p> <p> Recommended for reconstitution using bacteriostatic water within controlled laboratory preparation environments. </p> <p> Each vial contains 10mg of high-purity lyophilised Tesamorelin intended strictly for analytical, laboratory, and scientific research applications. </p> <p> <strong>For research use only. Not for human consumption.</strong> </p>

Purity99.600%
Format10mg
Ships FromAustralia & New Zealand
MOQ1 vial

Available variants

10MG × 1$97.00In Stock
10MG × 10$728.00In Stock

Product description

Product Overview

Tesamorelin is a synthetic growth hormone releasing hormone analogue supplied by Vital Edge Science for laboratory research involving growth hormone signalling, IGF-1 modulation, metabolic regulation, recovery pathways, and endocrine system investigations. This batch features independent Janoshik verification and Australia/New Zealand fulfilment support.

Available Formats

  • 10mg × 1 vial
  • 10mg × 10 vials
  • MOQ: 1 vial
  • Australia / New Zealand fulfilment

Batch Verification

  • Purity: 99.600%
  • Tested: 20 OCT 2025
  • Task Number: #84093
  • Verification Key: 4HFT88W8WIBT

Research Applications

  • Growth hormone signalling research
  • IGF-1 pathway investigations
  • Metabolic regulation studies
  • Recovery optimisation models
  • Endocrine system research

Verification report

Report typeJanoshik / COA
Task number#84093
Unique ID4HFT88W8WIBT
Tested20 OCT 2025
Open reportTesamorelin COA